ORE PHARMACEUTICALS Trademark Information

ORE PHARMACEUTICALS INC.

pharmaceutical product evaluation, research and development

Words that describe this mark

pharmaceuticals       small   molecules   repositioned   original   research   indication   alternate   indication  

This is a brand page for the ORE PHARMACEUTICALS trademark by ORE PHARMACEUTICALS INC.  in Cambridge, MA, 02142.

Write a review about a product or service associated with this ORE PHARMACEUTICALS trademark. Or, contact the owner ORE PHARMACEUTICALS INC. of the ORE PHARMACEUTICALS trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the ORE PHARMACEUTICALS trademark.

On Friday, October 19, 2007, a U.S. federal trademark registration was filed for ORE PHARMACEUTICALS. The USPTO has given the ORE PHARMACEUTICALS trademark serial number of 77308650. The current federal status of this trademark filing is CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE. The correspondent listed for ORE PHARMACEUTICALS is JOSEPH E. WASHINGTON of TMSU, 1111 PENNSYLVANIA AVE NW, WASHINGTON DC 20004-2541 . The ORE PHARMACEUTICALS trademark is filed in the category of Computer & Software Services & Scientific Services . The description provided to the USPTO for ORE PHARMACEUTICALS is pharmaceuticals, namely, small molecules that have been repositioned from their original research indication to an alternate indication.

Word mark: ORE PHARMACEUTICALS
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
12/9/2016
Serial Number: 77308650
Filing Date: 10/19/2007
Registration Number: 3785232
Registration Date: 5/4/2010
Goods and Services: pharmaceuticals, namely, small molecules that have been repositioned from their original research indication to an alternate indication
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 4/21/2009
Last Applicant/Owner: ORE PHARMACEUTICALS INC.
Cambridge, MA 02142
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: ("PHARMACEUTICALS")
Correspondent:
TMSU
1111 PENNSYLVANIA AVE NW
WASHINGTON DC 20004-2541

Trademark Events

Event Date: Event Description
2016-12-09 CANCELLED SEC. 8 (6-YR)
2010-05-04 REGISTERED-PRINCIPAL REGISTER
2010-03-27 NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2010-03-26 LAW OFFICE REGISTRATION REVIEW COMPLETED
2010-03-19 ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2010-03-19 NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2010-03-18 STATEMENT OF USE PROCESSING COMPLETE
2010-01-14 USE AMENDMENT FILED
2010-03-18 EXTENSION 1 GRANTED
2010-01-14 EXTENSION 1 FILED
2010-03-17 CASE ASSIGNED TO INTENT TO USE PARALEGAL
2010-01-15 APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2010-01-15 TEAS CHANGE OF OWNER ADDRESS RECEIVED
2010-01-14 TEAS EXTENSION RECEIVED
2010-01-14 TEAS STATEMENT OF USE RECEIVED
2009-07-14 NOA MAILED - SOU REQUIRED FROM APPLICANT
2009-04-21 PUBLISHED FOR OPPOSITION
2009-04-01 NOTICE OF PUBLICATION
2009-03-17 LAW OFFICE PUBLICATION REVIEW COMPLETED
2009-03-17 APPROVED FOR PUB - PRINCIPAL REGISTER
2009-03-17 EXAMINER'S AMENDMENT ENTERED
2009-03-17 NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2009-03-17 EXAMINERS AMENDMENT E-MAILED
2009-03-17 EXAMINERS AMENDMENT -WRITTEN
2008-08-19 NOTIFICATION OF FINAL REFUSAL EMAILED
2008-08-19 FINAL REFUSAL E-MAILED
2008-08-19 FINAL REFUSAL WRITTEN
2008-08-01 TEAS/EMAIL CORRESPONDENCE ENTERED
2008-08-01 CORRESPONDENCE RECEIVED IN LAW OFFICE
2008-07-31 ASSIGNED TO LIE
2008-07-30 TEAS RESPONSE TO OFFICE ACTION RECEIVED
2008-04-02 AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2008-01-31 NOTIFICATION OF NON-FINAL ACTION E-MAILED
2008-01-31 NON-FINAL ACTION E-MAILED
2008-01-31 NON-FINAL ACTION WRITTEN
2008-01-30 ASSIGNED TO EXAMINER
2007-10-24 NEW APPLICATION ENTERED IN TRAM

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : 12/18/2007
First Use In Commerce: 12/18/2007

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your ORE PHARMACEUTICALS trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Current Trademark Status:
12/9/2016
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
Correspondent Search:

JOSEPH E. WASHINGTON is a correspondent of ORE PHARMACEUTICALS trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!